ArticleJournal of neuroengineering and rehabilitation2025
Disruption of low-frequency narrowband EEG microstate networks in Parkinson's disease with mild cognitive impairment.
Article in Journal of neuroengineering and rehabilitation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Time-Varying Effective Network of Rehabilitation in Parkinson's Disease With Disease Laterality: A TMS-EEG Study.CNS neuroscience & therapeutics · 2026Article
- Delta-Band EEG Microstate Dynamics as Promising Candidate Markers of Central Vertigo Severity.Brain sciences · 2026Article
- The phase average wavelength of alpha rhythm in EEG signals of patients with Parkinson's disease combined with cognitive impairment.PloS one · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundElectroencephalogram (EEG) microstates provide insights into large-scale brain network coordination, revealing distinct neural dynamics within specific frequency bands associated with cognitive processes and neurological disorders. Critical gaps remain regarding the abnormalities of narrowband microstate networks in Parkinson's disease with mild cognitive impairment (PD-MCI), a key prodromal stage of the development of PD dementia. Given the importance of early detection and understanding of cognitive decline in PD-MCI, this study investigated whether alterations in narrowband EEG microstate networks could serve as early electrophysiological biomarkers for cognitive decline in PD-MCI.
methodForty-seven individuals with PD (21 with MCI and 26 cognitively normal [PD-NC]) and 20 healthy controls were recruited. For both broadband and narrowband EEG microstates, the phase lag index was used to construct microstate brain networks, and their spatiotemporal variability was assessed.
resultsMicrostate analysis revealed significant divergence in narrowband parameters exclusively between the PD-MCI and PD-NC cohorts. PD-MCI showed a significant increase in low-frequency (delta/alpha-band) microstate class A, while delta-band microstate class D exhibited a significant reduction. The microstate network patterns of PD-MCI were characterized by diminished stability and disrupted synchronization in delta microstate class A within the frontal region, theta microstate class D within central region, and theta microstate class B within the occipital region. These neurophysiological markers specific to PD-MCI were significantly correlated with Montreal Cognitive Assessment scores, and machine learning-based analyses further validated their diagnostic efficacy, with accuracy ranging from 94 to 98%.
conclusionsThis study identified unique abnormalities in narrowband microstate dynamics within neural networks of individuals with PD-MCI, revealing promising electrophysiological markers for the early detection and longitudinal monitoring of cognitive decline. Furthermore, these findings suggest potential applications in precision rehabilitation, whereby frequency-specific microstate biomarkers could guide individualized interventions and monitor therapeutic efficacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.